Inactive Instrument

Zenyth Therapeutics Limited Stock

ZTL

AU000000ZTL7

Zenyth Therapeutics, Ltd. develops pharmaceutical and biotechnology products in the therapeutic areas of hematology, bladder cancer and anti-virals. The Company's core business is the research and development medicines to treat human diseases. Zenyth's in-house pharmaceutical R&D is focused on three key areas: infectious diseases, neurological disease, and allergy and inflammation. Its R&D activity targets the clinical development of compounds for serious chronic human diseases.

Employees

Sector

Pharmaceuticals

More about the company

Manager	Title	Age	Since
Andrew Nash CEO	Chief Executive Officer	-	-
Andrew Boyd DFI	Director of Finance/CFO	-	2011-02-28
S. D. B. Scrofani PRN	Corporate Officer/Principal	-	2011-02-28

Director	Title	Age	Since
Andrew Nash BRD	Director/Board Member	-	2011-02-28
Brian McNamee BRD	Director/Board Member	70	-
Antoni M. Cipa BRD	Director/Board Member	-	-

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	Average
	Weighted average by Cap.

Zenyth Therapeutics Limited Stock

Stocks

ZTL

AU000000ZTL7

Pharmaceuticals

Managers and Directors: Zenyth Therapeutics Limited

Biopharmaceuticals

Company Profile

End-of-day quote Australian S.E.
-	-